Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Avastin 400
Dosage Form : INF
Dosage Strength : 400mg/16ml
Packaging : 16X1mg/16ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Avastin 100
Dosage Form : INF
Dosage Strength : 100mg/4ml
Packaging : 4X1mg/4ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Abevmy 400mg
Dosage Form : INF
Dosage Strength : 400mg/16ml
Packaging : 16X1mg/16ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Abevmy 100mg
Dosage Form : INF
Dosage Strength : 100mg/4ml
Packaging : 4X1mg/4ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Bevamyl 400mg
Dosage Form : INF
Dosage Strength : 400mg/16ml
Packaging : 16X1mg/16ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Bevamyl 100mg
Dosage Form : INF
Dosage Strength : 100mg/4ml
Packaging : 4X1mg/4ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Related Excipient Companies
Excipients by Applications
18 Sep 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/esmo-innovent-links-cytokine-fusion-protein-responses-colorectal-cancer
17 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/innovent-announces-clinical-data-of-ibi363-first-in-class-pd-1il-2-bias-bispecific-antibody-fusion-protein-combined-with-bevacizumab-in-advanced-colorectal-cancer-at-the-2024-esmo-congress-302250106.html
14 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/14/2946228/0/en/Sutro-Biopharma-Announces-Updated-Data-from-Phase-1b-Study-of-Luvelta-in-Combination-with-Bevacizumab-at-ESMO-2024.html
13 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/13/2945976/0/en/Outlook-Therapeutics-Participates-in-the-2nd-Annual-Chardan-Virtual-Ophthalmology-Conference-Series.html
04 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/04/2940523/0/en/Outlook-Therapeutics-Announces-Completion-of-Enrollment-in-NORSE-EIGHT-Clinical-Trial.html
03 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/03/2939723/0/en/Outlook-Therapeutics-to-Present-at-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?